Abstract

BackgroundExcess body weight is a major risk factor for cardiometabolic diseases. The complex molecular mechanisms of body weight change-induced metabolic perturbations are not fully understood. Specifically, in-depth molecular characterization of long-term body weight change in the general population is lacking. Here, we pursued a multi-omic approach to comprehensively study metabolic consequences of body weight change during a seven-year follow-up in a large prospective study.MethodsWe used data from the population-based Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 cohort. At follow-up (F4), two-platform serum metabolomics and whole blood gene expression measurements were obtained for 1,631 and 689 participants, respectively. Using weighted correlation network analysis, omics data were clustered into modules of closely connected molecules, followed by the formation of a partial correlation network from the modules. Association of the omics modules with previous annual percentage weight change was then determined using linear models. In addition, we performed pathway enrichment analyses, stability analyses, and assessed the relation of the omics modules with clinical traits.ResultsFour metabolite and two gene expression modules were significantly and stably associated with body weight change (P-values ranging from 1.9 × 10−4 to 1.2 × 10−24). The four metabolite modules covered major branches of metabolism, with VLDL, LDL and large HDL subclasses, triglycerides, branched-chain amino acids and markers of energy metabolism among the main representative molecules. One gene expression module suggests a role of weight change in red blood cell development. The other gene expression module largely overlaps with the lipid-leukocyte (LL) module previously reported to interact with serum metabolites, for which we identify additional co-expressed genes. The omics modules were interrelated and showed cross-sectional associations with clinical traits. Moreover, weight gain and weight loss showed largely opposing associations with the omics modules.ConclusionsLong-term weight change in the general population globally associates with serum metabolite concentrations. An integrated metabolomics and transcriptomics approach improved the understanding of molecular mechanisms underlying the association of weight gain with changes in lipid and amino acid metabolism, insulin sensitivity, mitochondrial function as well as blood cell development and function.Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-015-0282-y) contains supplementary material, which is available to authorized users.

Highlights

  • Excess body weight is a major risk factor for cardiometabolic diseases

  • We aimed to characterize associations of body weight change over a seven-year follow-up period with serum metabolomics and whole blood transcriptomics data assessed at follow-up, to determine distinct groups of molecules associated with weight change using weighted correlation network analysis (WGCNA), to study the interrelation of these groups using partial correlation networks, to investigate the stability of the findings in relevant subgroups and upon additional multivariable adjustment, for example, of subjects with weight gain versus weight reduction, and to determine the relation of the identified omics signatures with clinical traits

  • Body weight change is globally associated with the metabolite profile Four of the eight metabolite modules (MetM) were significantly associated with annual percentage body weight change (ΔBW), in linear models adjusted for age, sex and baseline body weight

Read more

Summary

Introduction

Excess body weight is a major risk factor for cardiometabolic diseases. The complex molecular mechanisms of body weight change-induced metabolic perturbations are not fully understood. Considering the manifold health problems associated with excess body weight, including cardiovascular disease and type 2 diabetes, obesity poses a serious public health problem [2]. Understanding the mechanisms by which excess body weight contributes to cardiometabolic risk is a prerequisite for advances in therapeutic approaches. The complex molecular basis of body weight-related metabolic perturbations is not fully understood. Weight loss upon behavioral intervention was associated with changes in the blood metabolome [5,10], suggesting that the observed obesity-related molecular signatures are at least in part reversible

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call